Status:
COMPLETED
Duragen Versus Duraguard in Chiari Surgery
Lead Sponsor:
University of Illinois at Chicago
Conditions:
Chiari Malformation
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The study evaluates two materials used for duraplasty of the posterior cranial fossa in treatment of Chiari malformation. One material (DuraGen) is a non-suturable collagen matrix that is applied over...
Detailed Description
The study is aimed at comparative analysis of two frequently used duraplasty materials: one is made out of bovine pericardium, and the other - from bovine collagen derived from bovine achilles tendon....
Eligibility Criteria
Inclusion
- Symptomatic Chiari malformation
Exclusion
- Presence of ventriculoperitoneal shunt
- Pregnancy
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT00741858
Start Date
April 1 2003
End Date
April 1 2010
Last Update
July 13 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois Medical Center in Chicago
Chicago, Illinois, United States, 60612